WHO Technical Report Series, No. 981 - World Health Organization

14. Miscellaneous
14.1 Quality assurance of pharmaceuticals: a compendium
of guidelines and related materials
The Expert Committee was informed that a CD-ROM had been produced
containing a compendium of all current WHO guidelines and related materials
on quality assurance.
14.2 Strategy
All areas of WHO had been requested to prepare strategies that would guide
their future activities. Members of the Expert Committee were invited to propose
elements that could be included in the future strategy of QSM.
Topics raised included:
■■
■■
■■
■■
■■
biosimilars, which relate both to biologicals and pharmaceutical
preparations, through increased liaison and collaboration with the
Expert Committee on Biological Standardization;
increased collaboration between pharmacopoeias and
harmonization;
increased availability of international expertise to national
laboratories (in particular in view of the increased need to identify
SFFC drugs);
facilitation of training for NMRAs;
prioritization, especially to retain and maintain the current core
activities in this area.
WHO Technical Report Series, No. 981, 2013
36